Evaluation of Effectiveness and Safety of BIOMATRIX Stent (IRIS-BIOMATRIX)

CompletedOBSERVATIONAL
Enrollment

837

Participants

Timeline

Start Date

May 31, 2010

Primary Completion Date

July 1, 2016

Study Completion Date

August 14, 2020

Conditions
Coronary Artery Disease
Trial Locations (20)

Unknown

Soon Chun Hyang University Hospital Cheonan, Cheonan

Daegu Catholic University Medical Center, Daegu

Keimyung University Dongsan Medical Center, Daegu

The Catholic University of Korea, Daejeon ST. Mary's Hospital, Daejeon

Chonnam National University Hospital, Gwangju

National Health Insurance Corporation Ilsan Hospital, Ilsan

Gachon University Gil Hospital, Incheon

Inha University Hospital, Incheon

Gyeongsang National University Hospital, Jinju

Kwangju Christian Hospital, Kwangju

Dong-A Medical Center, Pusan

Inje University Pusan Paik Hospital, Pusan

Asan Medical Center, Seoul

Eulji general hospital, Seoul

Gangnam Severance Hospital, Seoul

Korea University Anam Hospital, Seoul

Korea University Guro Hospital, Seoul

The Catholic University of Korea St. Paul's Hospital, Seoul

The Catholic University of Korea, Seoul St.Mary's Hospital, Seoul

The Catholic University of Korea Uijeongbu St. Mary's Hospital, Uijeongbu-si

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

CardioVascular Research Foundation, Korea

OTHER

collaborator

Dio

INDUSTRY

lead

Seung-Jung Park

OTHER

NCT01350778 - Evaluation of Effectiveness and Safety of BIOMATRIX Stent (IRIS-BIOMATRIX) | Biotech Hunter | Biotech Hunter